Evidence map›Paper›PMID 38954728›Full record

ArticlePLoS computational biology2024

Detection of disease-specific signatures in B cell repertoires of lymphomas using machine learning.

Paul Schmidt-Barbo, Gabriel Kalweit, Mehdi Naouar, Lisa Paschold, Edith Willscher, Christoph Schultheiß, Bruno Märkl, Stefan Dirnhofer, Alexandar Tzankov, Mascha Binder and 1 more

Abstract read
In one paragraph

Article in PLoS computational biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. AI-Driven BCR Modeling for Precision Immunology.International journal of molecular sciences · 2026
    Review
  2. Article
  3. Article
  4. Challenges and future directions of AIRR-seq-based diagnostics.Immunoinformatics (Amsterdam, Netherlands) · 2025
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Paul Schmidt-BarboDepartment of Biomedicine, Translational Immuno-Oncology, University Hospital Basel, Basel, Switzerland.ORCID 0009-0008-0871-7555
Gabriel KalweitCollaborative Research Institute Intelligent Oncology (CRIION), Freiburg, Germany.
Mehdi NaouarCollaborative Research Institute Intelligent Oncology (CRIION), Freiburg, Germany.
Lisa PascholdInternal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
Edith WillscherInternal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
Christoph SchultheißDepartment of Biomedicine, Translational Immuno-Oncology, University Hospital Basel, Basel, Switzerland.ORCID 0000-0001-9789-5776
Bruno MärklPathology, University Hospital Augsburg, Augsburg, Germany.
Stefan DirnhoferPathology, University Hospital Basel, Basel, Switzerland.
Alexandar TzankovPathology, University Hospital Basel, Basel, Switzerland.
Mascha BinderDepartment of Biomedicine, Translational Immuno-Oncology, University Hospital Basel, Basel, Switzerland.ORCID 0000-0003-0663-3004
Maria KalweitCollaborative Research Institute Intelligent Oncology (CRIION), Freiburg, Germany.

Funding

Mertelsmann Foundation
6 · The paper itself

Abstract

The classification of B cell lymphomas-mainly based on light microscopy evaluation by a pathologist-requires many years of training. Since the B cell receptor (BCR) of the lymphoma clonotype and the microenvironmental immune architecture are important features discriminating different lymphoma subsets, we asked whether BCR repertoire next-generation sequencing (NGS) of lymphoma-infiltrated tissues in conjunction with machine learning algorithms could have diagnostic utility in the subclassification of these cancers. We trained a random forest and a linear classifier via logistic regression based on patterns of clonal distribution, VDJ gene usage and physico-chemical properties of the top-n most frequently represented clonotypes in the BCR repertoires of 620 paradigmatic lymphoma samples-nodular lymphocyte predominant B cell lymphoma (NLPBL), diffuse large B cell lymphoma (DLBCL) and chronic lymphocytic leukemia (CLL)-alongside with 291 control samples. With regard to DLBCL and CLL, the models demonstrated optimal performance when utilizing only the most prevalent clonotype for classification, while in NLPBL-that has a dominant background of non-malignant bystander cells-a broader array of clonotypes enhanced model accuracy. Surprisingly, the straightforward logistic regression model performed best in this seemingly complex classification problem, suggesting linear separability in our chosen dimensions. It achieved a weighted F1-score of 0.84 on a test cohort including 125 samples from all three lymphoma entities and 58 samples from healthy individuals. Together, we provide proof-of-concept that at least the 3 studied lymphoma entities can be differentiated from each other using BCR repertoire NGS on lymphoma-infiltrated tissues by a trained machine learning model.

Indexed as

Machine LearningReceptors, Antigen, B-CellAlgorithmsB-LymphocytesComputational BiologyHigh-Throughput Nucleotide SequencingHumansLeukemia, Lymphocytic, Chronic, B-CellLymphoma, B-CellLymphoma, Large B-Cell, DiffuseReceptors, Antigen, B-Cell

Identifiers

PMID38954728
PMCPMC11249212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.